Pen starts with hair loss treatment in Latin America, but the real value is not just helping users begin. It is building a care flow that carries patient context forward across every review.
Pen is the first real product built on Soficca — a monetizable entry point that validates governed intake, clinical decision logic, and follow-up over time with real users.
The gap is not only access to treatment. It is what happens after treatment begins.
Medication access may be fragmented, but the bigger failure is continuity: follow-up, progress tracking, and next-step care are often manual, inconsistent, or missing.
Online access is starting to exist, but continuity still does not. That leaves room for a more structured treatment workflow.
The real gap is not only access to treatment, but what happens after treatment begins.
Across early cases, we kept seeing the same pattern: fragmented access, weak medication control, and follow-up that is often manual or missing.
That is what pushed Pen beyond one-time evaluation and toward a structured longitudinal workflow.
Pen is a real treatment path: governed intake, decision logic, treatment selection, and follow-up checkpoints over time.
A real checkpoint inside Pen's treatment flow. This is where follow-up becomes visible over time.
Most digital treatment options help users start. Pen is being built to make each next review more informed by preserving case history and review context over time.
Pen is the first monetized product built on Soficca. The initial pricing is designed to be accessible in Latin America while covering intake, treatment, and follow-up.
From first build to real intake, Pen has been developed as a functioning product rather than a deck concept — combining real intake, decision logic, and follow-up design.
Pen's clinical audit and regulatory alignment is supported by an external advisor with direct healthcare operations experience.
10+ years in healthcare operations and regulatory processes in Colombia. Currently at Nueva EPS. Advises Soficca on documentation discipline, audit-readiness, and regulatory alignment.
Pen began as a treatment workflow, but building it made the underlying need clear: structured routing, follow-up logic, and continuity could not remain one-off product decisions.
Soficca is the reusable decision layer that emerged underneath that workflow.
Pen validates the decision layer. Soficca is the infrastructure that scales it — the same governed intake, safety logic, and care context applied across additional conditions and environments.
See Soficca →